Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable. In others, the dividend is so low, it's not even worth the paper your dividend check is printed on. A�solid dividend�strikes the right balance of growth, value, and sustainability.
Today, and one day each week for the rest of the year, we're going to look at one dividend-paying company that you can put in your portfolio for the long term without too much concern. This isn't to say that these stocks don't share the same macro risks that other companies have, but they are a step above your common grade of dividend stock. Check out�last week's selection.
This week, we'll turn our attention to a company that literally keeps America trucking, Cummins (NYSE: CMI ) , and I'll show you why it and its dividend could drive your portfolio to big gains.
Cummins, a manufacturer of diesel and natural gas engines, as well as a provider of engine components and power generation products, has soared some 500% since its recession lows. The most amazing aspect about this heavy-duty engine maker is that it could still have plenty of room to run higher.
Top 5 Trucking Stocks To Buy Right Now: ProShares Ultra 7-10 Year Treasury (UST)
NA
Advisors' Opinion:- [By Donald van Deventer]
Long-duration Treasury Exchange-Traded Funds: (TLH), , (IEF), (DTYL), (DLBL), (ILTB), (TENZ), (ITE), (TLO), (EDV), (VGIT), (VGLT), (TMF), (TYD), (LBND), (UBT), (UST), (TMV), (TYO), (DSTJ), (DSXJ), (SBND), (PST), (DTYS), (DLBS), (TBF), (TTT), (TYNS), (TYBS), (TBX).
Top 5 Trucking Stocks To Buy Right Now: Merrimack Pharmaceuticals Inc (MACK)
Merrimack Pharmaceuticals, Inc., incorporated in 1993, is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. The Company�� product candidates include MM-398, MM-121, MM-111, MM-302 and MM-151. As of June 31, 2011, the Company owned approximately 74% interest of Silver Creek.
The Company�� Network biology is an interdisciplinary approach to drug discovery and development that enables the Company to build functional and predictive computational models of biological systems based on quantitative, kinetic, multiplexed biological data. The Company provides its scientists with insights into how the complex molecular interactions that occur within cell signaling pathways, or networks, regulate cell decisions and how dysfunction within these networks leads to disease. The Company applies network biology throughout the research and development process, including for target identification, lead compound design and optimization, diagnostic discovery, in vitro and in vivo predictive development and the design of clinical trial protocols.
MM-398
MM-398 is a stable nanotherapeutic encapsulation, or enclosed sphere carrying an active drug, of the marketed chemotherapy drug irinotecan. MM-398 achieved its primary efficacy endpoints in Phase 2 clinical trials in pancreatic and gastric cancer. In an open label, single arm Phase 2 clinical trial of MM-398 as a monotherapy in 40 metastatic pancreatic cancer patients who had previously failed treatment with gemcitabine, patients treated with MM-398 achieved median overall survival of 22.4 weeks. Additionally, 20% of the patients in this Phase 2 trial survived for more than one year, and the Company observed a disease control rate, meaning patients exhibited stable disease or partial or complete response to treatment, of 47.5% at six weeks.
The Company focuses on initiati! ng a Phase 3 clinical trial of MM-398 for the treatment of patients with metastatic pancreatic cancer who have previously failed treatment with gemcitabine. The trial is expected to enroll approximately 250 patients and is designed to compare the efficacy of MM-398 as a monotherapy against the combination of the chemotherapy drugs fluorouracil, or 5-FU, and leucovorin. There are multiple ongoing Phase 1 and Phase 2 clinical trials of MM-398. In July 2011, the United States Food and Drug Administration (FDA) granted MM-398 orphan drug designation for the treatment of pancreatic cancer.
MM-121
MM-121 is a fully human monoclonal antibody that targets ErbB3, a cell surface receptor, or protein attached to the cell membrane that mediates communication inside and outside the cell, that the Company�� network biology approach identified as a target in a range of cancers. A monoclonal antibody is a type of protein normally produced by cells of the immune system that binds to just one epitope, or chemical structure, on a protein or other structure. MM-121 is designed to inhibit cancer growth directly, restore sensitivity to drugs to which a tumor has become resistant and delay the development of resistance of a tumor to other agents. In collaboration with Sanofi, the Company focuses on testing MM-121 in combination with both chemotherapies and other targeted agents across a range of spectrum of solid tumors, including lung, breast and ovarian cancers. The Company partnered MM-121 with Sanofi after it initiated Phase 1 clinical development of the product candidate.
MM-111
MM-111 is a bispecific antibody designed to target cancer cells that are characterized by overexpression of the ErbB2 cell surface receptor, also referred to as HER2. A bispecific antibody is a type of antibody that is able to bind simultaneously to two distinct proteins or epitopes. The Company�� network biology approach identified that ligand-induced signaling through the complex of ErbB2 ! (HER2) an! d ErbB3 is a promoter of tumor growth and survival than previously appreciated.
MM-302
MM-302 is a nanotherapeutic encapsulation of doxorubicin with attached antibodies that are designed to target MM-302 to cells that over express the ErbB2 (HER2) receptor. The Company is conducting a Phase 1 clinical trial of MM-302 in patients with advanced ErbB2 (HER2) positive breast cancer.
MM-151
MM-151 is an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor (EGFR). EGFR is also known as ErbB1. An oligoclonal therapeutic is a mixture of two or more distinct monoclonal antibodies. The Company has designed MM-151 to block signal amplification that occurs within the ErbB cell signaling network. The Company has submitted an investigational new drug application (IND), to the FDA for MM-151 in July 2011.
Advisors' Opinion:- [By Eric Volkman]
Merrimack Pharmaceuticals (NASDAQ: MACK ) is gearing up for a double dose of fund-raising. The company announced that it will concurrently float both a common stock and a convertible notes issue in a public offering. In the former, Merrimack will offer $50 million worth of shares, while the latter will take the form of $75 million in senior notes maturing in 2020. Additionally, the company expects that it will grant its underwriters a 30-day purchase option for up to an additional $7.5 million worth of common shares and $11.25 million of the convertible notes.
- [By Roberto Pedone]
One under-$10 biopharmaceuticals player that's just starting to trigger a breakout trade is Merrimack Pharmaceuticals (MACK), which focuses on discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. This stock has been hit hard by the bears so far in 2013, with shares off by 38%.
If you take a look at the chart for Merrimack Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last two months, with shares plunging from its high of 7.09 to its recent low of $3.26 a share. During that move, shares of MACK have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of MACK have just formed a double bottom chart pattern at $3.26 to $3.32 a share and it's now starting to break out above some near-term overhead resistance at $3.64 a share. This move could be signaling a trend change for MACK as the stock starts to move higher off oversold conditions.
Traders should now look for long-biased trades in MACK if it manages to break out above some near-term overhead resistance at $3.64 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.87 million shares. If that breakout triggers soon, then MACK will set up to re-test or possibly take out its next major overhead resistance level at its 50-day moving average of $4.75 a share. Any high-volume move above that level and above more resistance at $5.06 will then give MACK a chance to tag its 200-day moving average at $5.71 a share.
Traders can look to buy MACK off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.32 or at $3.26 a share. One can also buy MACK off strength once it clears $3.64 a share with volume and then simply use a stop tha
- [By Keith Speights]
Not so merry
Merrimack Pharmaceuticals (NASDAQ: MACK ) shareholders have had reason to party since early May, with the stock surging more than 60%. The merriment came to a stop this week, though, as shares tanked by 27%. - [By Monica Gerson]
Merrimack Pharmaceuticals (NASDAQ: MACK) dipped 15.38% to $2.86 after the company reported that Phase 2 study Of MM-121 missed primary endpoint.
IAC/InterActiveCorp (NASDAQ: IACI) shares fell 14.51% to $49.50 in the pre-market trading after the company reported downbeat Q3 revenue.
10 Best Penny Stocks To Buy Right Now: Eaton Vance Corporation (EV)
Eaton Vance Corp., through its subsidiaries, engages in the creation, marketing, and management of investment funds in the United States. It also provides investment management and counseling services to institutions and individuals. Further, the company operates as an adviser and distributor of investment companies and separate accounts. As of October 31, 2004, the company provided investment advisory or administration services to approximately 150 funds; approximately 1,300 separately managed individual and institutional accounts; and participated in approximately 40 retail-managed account broker/dealer programs. It markets and distributes shares of funds through a retail network of national and regional broker/dealers, banks, insurance companies, and financial planning firms. Eaton Vance Corp. was founded in 1944 and is headquartered in Boston, Massachusetts.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Eaton Vance (NYSE: EV ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Eaton Vance (NYSE: EV ) , whose recent revenue and earnings are plotted below.
Top 5 Trucking Stocks To Buy Right Now: Mengold Resources Inc. (MNI.V)
MGold Resources Inc. engages in mineral exploration for precious and base metals in Canada. It primarily explores for gold, copper, lead, nickel, zinc, and molybdenum deposits. It holds interests in the Burchell Lake and Goldcreek properties located in the Shebandowan area of northwestern Ontario. The company was formerly known as Mengold Resources Inc. and changed its name to MGold Resources Inc. in September 2010. MGold Resources Inc. was incorporated in 1946 and is based in Montreal, Canada.
Top 5 Trucking Stocks To Buy Right Now: Brookdale Senior Living Inc. (BKD)
Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates in six segments: Retirement Centers, Assisted Living, Continuing Care Retirement Communities (CCRCs)�Rental, CCRCs-Entry Fee, Innovative Senior Care, and Management Services. The Retirement Centers segment owns or leases communities comprising independent living and assisted living units in a single community that are primarily designed for middle to upper income senior citizens. The Assisted Living segment owns or leases communities consisting of freestanding, multi-story communities, and freestanding single story communities, which offer housing and 24-hour assistance to mid-acuity frail and elderly residents. This segment also operates memory care communities for residents with Alzheimer's disease and other dementias. The CCRCs-Rental segment owns or leases communities that offer various living arrangements and services to accommodate physical ability and health. The CCRCs-Entry Fee segment allows residents in the independent living apartment units to pay a one-time upfront entrance fee to use certain amenities and services. The Innovative Senior Care segment provides outpatient therapy, home health, and hospice services to residents of its communities and other senior living communities. The Management Services segment operates third party communities under the management agreements. As of December 31, 2012, it operated 76 retirement center communities with 14,528 units; 433 assisted living communities with 21,594 units; 27 rental CCRC communities with 6,748 units; 14 entry fee CCRC communities with 5,866 units; and 97 communities with 17,998 units for third parties. Brookdale Senior Living Inc. is based in Brentwood, Tennessee.
Advisors' Opinion:- [By Tom Lydon]
Top holdings based on the index include Acadia Healthcare Companies (ACHC), Amsurg Corporation (AMSG), Brookdale Senior Living (BKD), Clarcor (CLC) and Community Health Systems (CYH).
Top 5 Trucking Stocks To Buy Right Now: Dupont Fabros Technology Inc. (DFT)
DuPont Fabros Technology, Inc., a real estate investment trust (REIT), engages in the ownership, acquisition, development, operation, management, and lease of large-scale data center facilities in the United States. The company leases its data centers to the American and international technology companies to house, power, and cool the computer servers that support their critical business processes. It also provides certain technical services to tenants, including layout design and installation of electrical power circuits, data cabling, server cabinets and racks, computer room airflow analyses, and monitoring. As of December 31, 2011, the company owned and operated seven data centers located in Northern Virginia; one data center in suburban Chicago, Illinois; one data center in Piscataway, New Jersey; one data center in Santa Clara, California. DuPont Fabros Technology, Inc. has elected to be taxed as a REIT. As a REIT, it would not be subject to federal corporate income t axes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2007 and is headquartered in Washington, District of Columbia.
Advisors' Opinion:- [By Ong Kang Wei]
For example, Digital Realty (DLR) is the undoubted leader in the data storage industry, with a market cap of $8.3B. Its other three competitors, DuPont Fabros (DFT), CoreSite Realty (COR) and CyrusOne (CONE), have market caps of $1.5B, $930M and $430M respectively. In addition, with the level of complexity involving Digital's business making it immensely difficult for companies to operate data centre facilities, the company is in a good position for future growth. The company also has a wide network of 595 tenants (significantly more than other competitors), including CenturyLink (CTL), AT&T and Morgan Stanley (MS). This further secures its long term business prospects and also its dominance over its competitors.
- [By alicet236]
Dupont Fabros Technology Inc. (DFT): President and CEO Hossein Fateh Sold 146,687 Shares
President and CEO of Dupont Fabros Technology Inc. (DFT) Hossein Fateh sold 146,687 shares on 01/10/2014 at an average price of $24.62. DuPont Fabros Technology Inc. was incorporated in March 2007 under the laws of the State of Maryland. Dupont Fabros Technology Inc. has a market cap of $1.61 billion; its shares were traded at around $24.92 with a P/E ratio of 100.90 and P/S ratio of 4.47. The dividend yield of Dupont Fabros Technology Inc stocks is 3.82%. Dupont Fabros Technology Inc. had an annual average earnings growth of 14.50% over the past five years.
- [By Rich Duprey]
As noted last month, DuPont Fabros Technology�� (NYSE: DFT ) �increased its�second-quarter dividend�25%, which will be paid on July 15 to shareholders of record on July 5. In addition to announcing this regular $0.25-per-share payout for its common stock, the data center operator also announced yesterday it would be paying dividends on two series of preferred stock, both of which will also be payable on July 15 to shareholders of record on July 5.
Top 5 Trucking Stocks To Buy Right Now: Nxa Inc. (NXI.V)
NXA Inc. does not have significant operations. It focuses on investigating for future business opportunities. Previously, the company was engaged in the exploration of base and precious metals. NXA Inc. is based in Toronto, Canada.
Top 5 Trucking Stocks To Buy Right Now: AmerisourceBergen Corp (ABC)
AmerisourceBergen Corporation (AmerisourceBergen), incorporated on March 16, 2001, is a pharmaceutical services companies serving the United States, Canada, and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. The Company distributes a range of pharmaceuticals (including specialty pharmaceutical products), generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. The Company also provides pharmacy services to certain specialty drug patients. In addition, the Company furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including pharmacy automation, inventories management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. The Company serves its customers (healthcare providers, pharmaceutical manufacturers, and specialty drug patients) through a network of distribution service centers and other operations in the United States, Canada, and global markets. In the Company's pharmaceutical distribution business, the Company is a source of supply of pharmaceutical and related products to its healthcare provider customers.
As of September 30, 2012, the Company's operations were comprised of the Pharmaceutical Distribution reportable segment and Other. Other consists of the AmerisourceBergen Consulting Services (ABCS) and World Courier operating segments. In September 2011, the Company acquired IntrinsiQ, LLC (IntrinsiQ) and Premier Source! . IntrinsiQ is a provider of informatics solutions, which help community oncologists make treatment decisions for their patients. Premier Source is a provider of consulting and reimbursement services to medical device, pharmaceutical, molecular diagnostic, and biotechnology manufacturers, as well as other health services companies. On November 1, 2011, the Company acquired TheraCom, LLC (TheraCom). TheraCom is a provider of commercialization support services to the biotechnology and pharmaceutical industry, including reimbursement and patient access support services. On April 30, 2012, the Company acquired World Courier Group, Inc. (World Courier), which is a global specialty transportation and logistics provider for the biopharmaceutical industry.
Pharmaceutical Distribution Segment
The Pharmaceutical Distribution reportable segment is consisted of two operating segments, which include the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG). Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. ABDC distributes a offering of brand-name pharmaceuticals (including specialty pharmaceutical products) and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. ABDC also provides pharmacy management, staffing and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets, and supply management software to a range of retail and institutional healthcare providers. In addition, ABDC delivers packaging solutions to institutional and retail healthcare providers.!
ABSG, through a range of operating businesses, provides pharmaceutical distribution and other services to physicians who specialize in a range of disease states, especially oncology, and to other healthcare providers, including dialysis clinics. ABSG also distributes plasma and other blood products, injectible pharmaceuticals and vaccines. In addition, ABSG provides third party logistics and other services for biotechnology and other pharmaceutical manufacturers. The Company's use of the term specialty and specialty pharmaceutical products refers to drugs used to treat complex diseases, such as cancer, diabetes, and multiple sclerosis. Specialty pharmaceutical products are part of complex treatment regimens for serious conditions and diseases, which require ongoing clinical monitoring.
Other
ABCS, through a number of operating businesses, provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and copay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers. World Courier, which operates in over 50 countries, is a specialty transportation and logistics provider for the biopharmaceutical industry. As of September 30, 2012, the Company committed to a plan to divest AndersonBrecon.
The Company competes with Cardinal Health, Inc., McKesson Corporation, FFF Enterprises, Henry Schein, Inc. and UPS Logistics.
Advisors' Opinion:- [By Rich Duprey]
The world's largest pharmaceuticals distributor, AmerisourceBergen (NYSE: ABC ) , has completed the divestiture of its Canadian�distribution business to�Kohl & Frisch Limited, the country's only Canadian-owned national full-line pharmaceutical distributor, AmerisourceBergen announced yesterday.
- [By Dividends4Life]
Memberships and Peers: CAH is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers��Index. The company's peer group includes: AmerisourceBergen Corporation (ABC) with a 1.3% yield, McKesson Corporation (MCK) with a 0.6% yield and Owens & Minor Inc. (OMI) with a 2.5% yield.
Top 5 Trucking Stocks To Buy Right Now: Dominion Resources Black Warrior Trust (DOM)
Dominion Resources Black Warrior Trust operates as a grantor trust in the United States. The company acquires and holds overriding royalty interests burdening proved natural gas properties that are owned by Walter Black Warrior Basin LLC and located in the Pottsville coal formation of the Black Warrior basin, Tuscaloosa county, Alabama. As of December 31, 2012, its underlying properties comprised 34,212 gross acres of land that contained 532 wells that were producing gas. The company was founded in 1994 and is based in Dallas, Texas.
Top 5 Trucking Stocks To Buy Right Now: Pericom Semiconductor Corporation(PSEM)
Pericom Semiconductor Corporation designs, develops, manufactures, and markets high performance digital, analog, and mixed-signal integrated circuits (ICs) and frequency control products (FCPs) used in electronic systems worldwide. The company?s products are used for the transfer, routing, and timing of digital and analog signals within and between computer, networking, data communications, and telecommunication systems. It offers SiliconConnect family products, including PCI and PCI-X bridges, PCI Express Bridges and packet switches, drivers, receivers, and transceivers, as well as low-voltage differential signaling products; SiliconSwitch family products comprising application-specific standard product switches, analog switches, and digital switches; SiliconInterface family products consisting of redrivers/signal conditioners, universal level shifters, lower balanced drives, application specific logic functions, 3.3-volt interface logic products, 5-volt FCT logic product s, and gates; and SiliconClock family products, such as clock buffers and zero-delay clock drivers, voltage controlled crystal oscillators, clock frequency synthesizers, and programmable clocks. The company?s FCPs include crystals that resonate at a frequency; and crystal oscillators used in various electronic devices. Its ICs and FCPs are used in various applications, such as notebook computers, servers, network switches and routers, storage area networks, digital TVs, cell phones, GPS, and digital media players. The company markets and distributes its products through a network of independent sales representatives and distributors to original equipment manufacturers and contract manufacturers in the computer, peripherals, networking, and telecommunications markets, as well as to end-user customers. Pericom Semiconductor Corporation was founded in 1990 and is headquartered in San Jose, California.
Top 5 Trucking Stocks To Buy Right Now: Goldcliff Resource Corporation(GCN.V)
Goldcliff Resource Corporation, a junior exploration company, engages in the acquisition and exploration of mineral properties in Canada. It holds 100% interests in the Panorama Ridge gold project covering an area of 8,980 hectares, located in the Nickel Plate mining district, Osoyoos Mining Division, British Columbia; and the Ainsworth silver project that covers an area of 10,280 hectares, located in the Kootenay mining district, Slocan Mining Division, British Columbia. The company also holds 100% interests in the Tulameen copper project comprising 26,333 hectares, located in the Princeton mining district, Similkameen Mining Division, British Columbia. Goldcliff Resource Corporation was founded in 1986 and is based in Vancouver, Canada.
No comments:
Post a Comment